Intrepid Capital Management’s Globus Medical GMED Stock Holding History

Intrepid Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Hold	28,509	–	–	0.8%	47
2026 Q1	$2.46M	Hold	28,509	–	–	0.94%	34
2025 Q4	$2.49M	Hold	28,509	–	–	0.96%	35
2025 Q3	$1.63M	Hold	28,509	–	–	0.64%	53
2025 Q2	$1.68M	Hold	28,509	–	–	0.68%	53
2025 Q1	$2.09M	Hold	28,509	–	–	1.01%	34
2024 Q4	$2.36M	Hold	28,509	–	–	1.2%	23
2024 Q3	$2.04M	Hold	28,509	–	–	1.13%	30
2024 Q2	$1.95M	Hold	28,509	–	–	1.24%	26
2024 Q1	$1.53M	Hold	28,509	–	–	0.99%	34
2023 Q4	$1.52M	Hold	28,509	–	–	1.04%	36
2023 Q3	$1.42M	Hold	28,509	–	–	0.98%	36
2023 Q2	$1.7M	Hold	28,509	–	–	1.19%	31
2023 Q1	$1.61M	Hold	28,509	–	–	1.4%	29
2022 Q4	$2.12M	Hold	28,509	–	–	1.83%	21
2022 Q3	$1.7M	Hold	28,509	–	–	1.38%	26
2022 Q2	$1.6M	Hold	28,509	–	–	1.27%	28
2022 Q1	$2.1M	Hold	28,509	–	–	1.25%	31
2021 Q4	$2.06M	Hold	28,509	–	–	1.05%	35
2021 Q3	$2.18M	Hold	28,509	–	–	1.08%	38
2021 Q2	$2.21M	Hold	28,509	–	–	1.17%	39
2021 Q1	$1.76M	Hold	28,509	–	–	0.92%	43
2020 Q4	$1.86M	Hold	28,509	–	–	0.94%	42
2020 Q3	$1.41M	Sell	28,509 -21,491	-43%	-$1.11M	0.82%	47
2020 Q2	$2.38M	Buy	+50,000	New	+$2.41M	1.35%	32

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Intrepid Capital Management's GMED Position: Q2 2026 in Review

Intrepid Capital Management held its Globus Medical (GMED) position steady in Q2 2026 at 28,509 shares worth $2.25M. The position accounts for 0.8% of the portfolio, ranked #47.

Intrepid Capital Management first reported a position in GMED in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.49M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Intrepid Capital Management held 28,509 shares of Globus Medical worth $2.25M as of Q2 2026.
Intrepid Capital Management left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up 0.8% of Intrepid Capital Management's portfolio in Q2 2026, its #47 holding.
Intrepid Capital Management first reported a position in Globus Medical in Q2 2020 and has held it in 25 quarters since.
Intrepid Capital Management's Globus Medical position peaked at $2.49M in Q4 2025.
597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Intrepid Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.